Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Clinuvel Pharmaceuticals (ASX: CUV): Research, Commercialisation and Pipeline Growth Drive Long-Term Strategy

• Research and development remain central to the company's long-term strategy.

Aditi Sarkar | 06 July 2026

Why Did Inoviq Ltd (ASX: IIQ) Shares Fall Today?

• The company is advancing precision diagnostics and cancer screening technologies.

Aditi Sarkar | 06 July 2026

Is CSL (ASX:CSL) Stock to Watch Right Now?

• The stock rose 1.99% in the latest trading session.

Sonal Goyal | 06 July 2026

Why Did Inoviq Ltd (ASX: IIQ) Shares Fall Today?

• The company is advancing precision diagnostics and cancer screening technologies.

Aditi Sarkar | 06 July 2026

Cynata Therapeutics (ASX: CYP) Surges 15%—What's Sparking the Market Buzz?

• The company is developing stem cell-based therapies targeting inflammatory, immune and degenerative diseases.

Aditi Sarkar | 06 July 2026

ASX: CU6 Climbs as Precision Oncology Developer Draws Market Attention

• The company is advancing a portfolio of precision oncology products for cancer diagnosis and treatment.

Aditi Sarkar | 06 July 2026

Is Sigma Healthcare Ltd (ASX:SIG) Worth Watching Despite a 6% One-Year Decline?

• The company continues expanding pharmaceutical distribution and pharmacy services.

Sonal Goyal | 06 July 2026

Telix Pharmaceuticals (ASX:TLX): The Nuclear Medicine Company Attracting Significant Investor Attention

Telix Pharmaceuticals Ltd (ASX:TLX) attracted investor attention in the latest trading session, with the stock trading at $17.57. The gain reflects continued interest from investors in the healthcare sector, where selected names have benefited from defensive positioning and sector-specific tailwinds. Market attention on Telix …

Sonal Goyal | 06 July 2026

Ryman Healthcare (ASX:RYM): Is This Retirement Village Operator Ready to Turn the Corner?

Ryman Healthcare Ltd (ASX:RYM) attracted investor attention in the latest trading session, with the stock trading at $1.80. The stock held steady, reflecting a period of consolidation as investors assess the company's near-term outlook amid broader healthcare sector dynamics. Market attention on Ryman Healthcare …

Sonal Goyal | 06 July 2026

Sonic Healthcare (ASX:SHL): Exploring the Business Behind Australia's Leading Pathology Provider

Sonic Healthcare Ltd (ASX:SHL) attracted investor attention in the latest trading session, with the stock trading at $21.61. The gain reflects continued interest from investors in the healthcare sector, where selected names have benefited from defensive positioning and sector-specific tailwinds. Market attention on Sonic …

Sonal Goyal | 06 July 2026
Support

Hi! How can we help you today?

Loading…